CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma
NCT04047303
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
20
Enrollment
INDUSTRY
Sponsor class
Stopped
Business objectives have changed.
Conditions
Astrocytoma
Glioblastoma
Interventions
DRUG:
CC-90010
Sponsor
Celgene